Moreover, CXCL1 levels in the blood are positively associated with both vascular endothelial growth factor (VEGF) levels and bone marrow microvessel density (MVD) in MM patients, suggesting a connection between CXCL1 and angiogenesis within the bone marrow [47]. This evidence concerns the gene VEGFA and Miyoshi myopathy.